Corvus Pharmaceuticals Inc. (CRVS) Declined -6.55% or -0.53 To Price $7.59 On Thursday


Corvus Pharmaceuticals Inc. (CRVS) declined -6.55% or -0.53 to $7.59. It is nearly 294167 shares traded, which is 355.79% compare to the average total volume 82680. The market cap of CRVS is $159.66 million. The year to date change is -27.31%. The 52 week price range is from $7.54 to $22.14. Price of CRVS have changed -0.37% during last week. It have changed -17.73% over last month, -22.67% over last 3 months, -31.88% over last 6 months and -39.58% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRVS is 9.61. It is 26.61% above current price. The 200-day Moving Averages for CRVS is 12.11. It is 59.55% above current price. The 52-week High is 22.14. It is 191.70% from the current price. The 52-week Low is 7.54. It is -0.66% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CRVS is 12.76 on 2018-01-31. Short % to float is 4.79%. There are some statistics of CRVS. It is has market cap $159.66 million. The share outstanding is 21.04 million. The average volume is 82680. The percent of top 15 Institution holding is 82.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRVS is -45.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRVS is -41.97%.


Tags:

Share this post